This announcement is a separate document:
中國抗體-B：完成根據一般授權認購新股份
SINOMAB BIO-B: COMPLETION OF SUBSCRIPTIONS OF NEW SHARESUNDER GENERAL MANDATE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated